Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0YC
|
|||
| Former ID |
DNC004851
|
|||
| Drug Name |
2-(4-Propyl-piperazin-1-yl)-quinoline
|
|||
| Synonyms |
CHEMBL180478; 2-(4-Propyl-piperazin-1-yl)-quinoline; Oprea1_188953; SCHEMBL3970431; 2-(4-Ethylpiperazino)quinoline; HEWVIFVVKWCRML-UHFFFAOYSA-N; BDBM50159120
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H19N3
|
|||
| Canonical SMILES |
CCN1CCN(CC1)C2=NC3=CC=CC=C3C=C2
|
|||
| InChI |
1S/C15H19N3/c1-2-17-9-11-18(12-10-17)15-8-7-13-5-3-4-6-14(13)16-15/h3-8H,2,9-12H2,1H3
|
|||
| InChIKey |
HEWVIFVVKWCRML-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem. 2005 Jan 13;48(1):306-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.